About this Event
Tina Cheng, PhD Candidate, will lead a discussion of the paper, What Is the Consensus Value of Patients’ Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease by Johnson et al.
Join us at our recurring journal club where an interest group member leads a discussion of a paper that features preference measurement methods. For September 2026, Tina Cheng will lead a discussion of What Is the Consensus Value of Patients’ Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease by Johnson FR, Gonzalez JM, Yang JC.
Note: Registrants will receive a link to the paper in their confirmation email.
